Global Migraine Market: Industry Analysis & Outlook (2018-2022)

Publisher Name :
Date: 07-Jun-2018
No. of pages: 75
Inquire Before Buying

Migraine is a chronic neurologic disease characterized by severe recurrent headaches. It is one of the most common and most prevalent disabling neurological conditions, characterized by episodes often called migraine attacks. They are quite different from regular headaches which are non-migrainous. Migraineurs generally have a lower threshold to triggers that might cause neuronal hyperexcitability, including sleep disturbances, environmental or emotional challenges, alcohol exposure, diet, and hormonal cycles/changes, among others.

Migraine headache is typically throbbing, unilateral (one sided), and is aggravated by physical activity. It typically presents with additional symptoms in addition to headache pain, including nausea, and sensitivity to light and/or sound.

Depending on symptoms, migraine is broadly classified into two categories, Chronic and Episodic. Migraines can be treated with two types of drugs: pain-relieving and preventive. Pain-relieving medications are especially useful for people who have nausea or vomiting related to their migraine, and they work quickly. Preventive treatment is considered if migraine occurs frequently, typically more than one migraine per week, or if migraine symptoms are severe.

The global migraine market is expected to grow in future due to increasing female population, rising health expenditure, accelerating economic growth, increasing cigarette consumption, rising prevalence of migraine and unmet needs. Key trends of this market include development of migraine drugs and growing awareness regarding migraine and its treatments. However, there are some factors which can hinder the growth of migraine market which includes regulatory challenges, high cost, adverse effects of drugs, lack of proper diagnosis and increased preference of alternative therapies.

The report “Global Migraine Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, with focus majorly on the U.S. market. The report profiles the key players of the market including Amgen Inc., Eli Lilly and Company, Teva Pharmaceuticals & Alder Biopharmaceuticals.

Global Migraine Market: Industry Analysis & Outlook (2018-2022)

Table of Contents

1. Overview
1.1 Introduction
1.2 Types
1.3 Stages
1.4 Diagnosis
1.5 Treatment

2. Global Market Analysis
2.1 Global Migraine Market by Value
2.2 Global Migraine Market Forecast by Value
2.3 Global Migraine Market by Drug Type
2.4 Global Therapeutic Botulinum Toxin Market Forecast by Value
2.5 Global Therapeutic Botulinum Toxin Market by Indication

3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Migraine Population Forecast
3.1.2 The U.S. Diagnosed & Treated Adult Migraine Population
3.1.3 The U.S. Migraine Population with CV Risk Factors
3.1.4 The U.S. Migraine Treatment by Specialty
3.1.5 The U.S. Migraine Treated Population by Drug Type
3.1.6 The U.S. Acute Migraine Prescription Volume
3.1.7 The U.S. Migraine Prophylaxis Market by Treatment
3.2 The U.S. Migraine Drugs Revenue
3.2.1 The U.S. Botox Migraine Revenue and Treated Patients
3.2.2 The U.S. Cambia Drug Revenue
3.2.3 The U.S. Lasmiditan Drug Revenue & Treated Patients
3.2.4 The U.S. Alder Drug Revenue
3.2.5 The U.S. Erenumab Drug Revenue and Treated Patients
3.2.6 The U.S. Galcanezumab Drug Revenue and Treated Patients
3.2.7 The U.S. Fremanezumab Drug Revenue and Treated Patients
3.3 Europe
3.3.1 Europe Total Migraine and Diagnosed Population
3.4 Europe Migraine Drug Revenue
3.4.1 Europe Alder Drug Revenue

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Female Population
4.1.2 Increasing Cigarette Consumption
4.1.3 Accelerating Economic Growth
4.1.4 Increasing Healthcare Spending
4.1.5 Rising Prevalence of Migraine Cases
4.1.6 Unmet Needs
4.2 Key Trends & Development
4.2.1 Migraine Drugs under Development
4.2.2 Growing Awareness for Migraine
4.3 Challenges
4.3.1 Adverse Effects of Drugs
4.3.2 Lack of Proper Diagnosis
4.3.3 Increased Preference for Alternative Therapies
4.3.4 Regulatory Challenges
4.3.5 High Cost Associated

5. Competition
5.1 Global Market
5.1.1 Global Migraine Market- Revenue Comparison of Key Companies
5.1.2 Global Migraine Market- Market Cap Comparison of Key Companies
5.1.3 Global Migraine Market- R&D Comparison of Key Companies

6. Company Profiles
6.1 Amgen Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Eli Lilly and Company
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Teva Pharmaceuticals
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Alder Biopharmaceuticals
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

List of Tables

Difference between Episodic and Chronic Migraine
Stages of Migraine
Migraine Drugs under Development (2017)
Alder Pharmaceuticals Pipeline Overview (2017)

List of Charts

Types of Migraine
Global Migraine Market by Value (2013-2017)
Global Migraine Market Forecast by Value (2018-2022)
Global Migraine Market by Drug Type (2017)
Global Therapeutic Botulinum Toxin Market Forecast by Value (2017-2022)
Global Therapeutic Botulinum Toxin Market by Indication (2017)
The U.S. Migraine Population Forecast (2017-2022)
The U.S. Diagnosed and Treated Adult Migraine Population (2017-2022)
The U.S. Migraine Population with CV Risk Factors (2017-2022)
The U.S. Migraine Treatment by Specialty (2017)
The U.S. Migraine Treated Population by Drug Type (2017)
The U.S. Acute Migraine Prescription Volume (2017-2022)
The U.S. Migraine Prophylaxis Market by Treatment (2017)
The U.S. Botox Migraine Revenue and Treated Patients (2017-2022)
The U.S. Cambia Drug Revenue (2017-2022)
The U.S. Lasmiditan Drug Revenue & Treated Patients (2018-2022)
The U.S. Alder Drug Revenue (2019-2024)
The U.S. Erenumab Drug Revenue and Treated Patients (2018-2022)
The U.S. Galcanezumab Drug Revenue and Treated Patients (2019-2024)
The U.S. Fremanezumab Drug Revenue and Treated Patients (2019-2024)
Europe Total Migraine and Diagnosed Population (2017-2022)
Europe Alder Drug Revenue (2021-2026)
Global Female Population (2013-2017)
Global Cigarette Consumption (2014-2017)
Global GDP Per Capita (2013-2017)
Global Healthcare Spending Per Capita (2013-2017)
Global Migraine Market-Revenue Comparison of Key Companies (2017)
Global Migraine Market- Market Cap Comparison of Key Companies (2017)
Global Migraine Market- R&D Comparison of Key Companies (2017)
Amgen Inc. Revenue by Geographic Region (2017)
Amgen Inc. Revenue and Net Income (2013-2017)
Amgen Inc. Research and Development Expenditure (2015-2017)
Eli Lilly and Company Revenue by Segments (2017)
Eli Lilly and Company Revenue and Net Income (2013-2017)
Eli Lilly and Company Research and Development Expenditure (2015-2017)
Teva Pharmaceuticals Revenue by Segments (2017)
Teva Pharmaceuticals Revenue and Net Income (2013-2017)
Alder Biopharmaceuticals Revenue and Net Income (2013-2017)
Alder Biopharmaceuticals Research & Development Expenditure (2015-2017)

  • 2018-2023 Global PEGylated Proteins Consumption Market Report
    Published: 15-Jun-2018        Price: US 4660 Onwards        Pages: 138
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global PEGylated Proteins market for 2018-2023. PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s. The threat of substitutes arises when there a......
  • 2018 Top 5 PEGylated Proteins Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 15-Jun-2018        Price: US 4960 Onwards        Pages: 125
    PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s. The threat of substitutes arises when there are similar products developed by competitors which satisfy the market needs. When consumers have access to substitute products which can satisfy their market needs, then manufacturer......
  • 2018-2023 Global Erythropoietin Consumption Market Report
    Published: 15-Jun-2018        Price: US 4660 Onwards        Pages: 131
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Erythropoietin market for 2018-2023. Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adult......
  • 2018 Top 5 Erythropoietin Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 15-Jun-2018        Price: US 4960 Onwards        Pages: 125
    Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood. Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, t......
  • Global Enzymatic Debridement Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Jun-2018        Price: US 3480 Onwards        Pages: 129
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Enzymatic Debridement Market 2018, Forecast to 2023
    Published: 15-Jun-2018        Price: US 4880 Onwards        Pages: 133
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, By End User, Companies
    Published: 14-Jun-2018        Price: US 1990 Onwards        Pages: 355
    Global Vaccine Market is projected to reach US$ 70 Billion by the year 2024. The vaccine market is likely to witness a significant growth throughout the forecast period due to the growing prevalence of diseases, increasing government and non-government funding for vaccine development & distribution and increasing investments by companies to develop new vaccines. Furthermore, growing demand for preventive vaccines, rising consciousness about vaccination coupled with mounting demand from th......
  • Global Celery Seed Extract Solid Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 13-Jun-2018        Price: US 3480 Onwards        Pages: 135
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Celery Seed Extract Solid Market 2018, Forecast to 2023
    Published: 13-Jun-2018        Price: US 4880 Onwards        Pages: 128
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs